Brown tumor is a non-neoplastic lesion which resulting from abnormal bone metabolism caused by hyperparathyroidism. We report a rare case of peripheral brown tumor related with primary hyperparathyroidism which simulating a peripheral giant cell granuloma of the jaws.
Introduction
Parathyroid hormone (PTH) is the chief regulator of calcium homeostasis in the human body.
Primary hyperparathyroidism (PHPT) occurs in a setting of excessive PTH secretion with an autonomous parathyroid gland, which results in hypercalcemia [1] . Most patients with PHPT have a single adenoma (about 80% of cases), but multigland disease can occur in 10%-15% of cases and double adenomas in 4%-5% [2] . Parathyroid carcinoma is a rare cause (usually less than 1% of patients) of hyperparathyroidism [3, 4] . There is a great variation in the manifestations of PHPT. The clinical presentation of PHPT ranges from a severe disease with nephrolithiasis and metabolic bone disease to mild asymptomatic disease [5, 6] . The most common clinical presentation of PHPT is asymptomatic hypercalcemia with an elevated or highor normal intact PTHlevel. Patients with hypercalcemia may present with vague constitutional symptoms, anorexia, lethargy, or polydipsia and polyuria [7] [8] [9] . Less specific features of PHPT are fatigue, proximal muscle weakness, mild cognitive disturbances, hypertension, left ventricular hypertrophy, valvular calcification and cardiovascular mortality [2, 10] . Classic skeletal lesions, which are bone resorption, bone cysts, brown tumours and generalized osteopenia, occur in less than 5% of cases [11] . PHPT affects compact bone more than trabecular bone with particular sensitivity in the cortices of long bones leading to subperiosteal bone resorption (seen as periosteal elevation on plain radiography) [12] . PHPT is prone to cause loss of the lamina dura [13] .
Giant cell lesions of bone share similar clinical, radiological and histological features. The most challenging differential diagnosis is between giant cell tumour and brown tumour due to hyperparathyroidism. Giant cell lesion associated with hyperparathyroidism is commonly named as "brown tumour". Brown tumour, also called osteitis fibrosa cystica,represents the terminal stage of the bone remodelling processes occurring as a result of peritrabecular fibrosis and osteoclastic activity [14, 15] . Brown tumours can occur as solitary or multiple lesions in any bone. The term of "brown tumour" comes from the colour of the lesion; which results from the vascularity, haemorrhage and deposits of haemosiderin [16] . Histologically, Informed consent was obtained from the patient. And, the patient underwent parathyroid surgery. After removing the parathyroid adenoma the serum calcium level decreased to 8 mg/dL and the PTH to 5.6 pg/mL. Calcium treatment was administered intravenously to the patient for three days and treatment was subsequently switched to calcitriol 0.5 µg tablet 2x1
and calcium 1000 mg tablet 3x1. Seven days after parathyroidectomy, serum calcium was 8.5
mg/dL and he was discharged. The patient is still on routine follow-up at our endocrinology outpatient clinic and has normal serum calcium levels. www.medicinescience.org | Med-Science 1758 Figure 3 . Tc99m-sestamibi parathyroid scintigraphy, revealed an area with increased uptake in the lower right thyroid lobe and another area with marked uptake lower than this level.
Discussion
PHPT is one of the most common endocrinological disorders [1] . Single gland parathyroid adenoma is the most common cause of PHPT. A single adenoma usually indicates sporadic disease, whereas hyperplasia of the four glands suggests familial disease (multiple endocrine neoplasia type 1 or 2A). Although PHPT is generally an asymptomatic disease detected by an incidental finding of hypercalcemia; in several cases, it has been diagnosed by overt bone disease. Bone involvement is the late manifestation of PHPT [19] . The brown tumour is a type of giant cell lesion and appears as multiple expansive osteolytic lesions of the bone. The ribs, clavicles, pelvic girdle, hand and the mandible are the bones which are most involved [20, 21] .
Peripheral manifestation of brown tumour on the oral cavity is rare, and the clinical appearance simulates peripheral giant cell granuloma. It is very difficult to distinguish histopathologically brown tumour from other giant cell lesions. So, the clinical diagnosis is made based on the association with PHPT [22] . There are very few cases presented in current literature, similar to oursi.e. brown tumour due to PHPT localized in the maxillary region.
The most useful therapy for patients with brown tumours is surgical excision of bone lesions and therapy (surgical or medical) for primary or secondary HPT. If PHPT is due to a parathyroid adenoma (or adenomas), parathyroidectomy is the definitive cure. Surgery has a very high long-term success rate and minimal morbidity [7, 8] . Most authors also agree that the best treatment for brown tumours is to cure the underlying PHPT. When a successful parathyroidectomy for PHPT has been performed, partial or total recovery of osteitis fibrosa cystica patterns has been described [23, 24] .
Medical therapy, such as calcimimetics, may gain in popularity with hypercalcemia patients who cannot undergo surgery. Although studies show that cinacalcet, versus placebo, effectively lowers both calcium and PTH levels, there is no significant increase in bone mineral density [25] [26] [27] . Multiple studies have shown that bisphosphonates improve bone mineral density on dual energy X-ray absorbsiometry (DXA) scans in patients with PHPT [28, 30] . If preservation of bone mineral density is the primary goal of treating asymptomatic PHPT, the agent of choice should be a bisphosphonate [7] .
Conclusion
We present a rare case of maxillar brown tumour associated with PHPT simulating a peripheral giant cell lesion. We also strongly emphasise the need for group consultation between oral and maxillofacial surgeons, dentists, endocrinologists and radiologists.
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